Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
The AICVD tool can predict the risk of cardiovascular disease.
Younger Indians have a 10 times higher rate of heart attack
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study
Bringing next-gen cannabinoid therapeutics to cancer patients
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium
CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit
Subscribe To Our Newsletter & Stay Updated
